HeyJaredVicki Moore
- Indexed articles, last 90 days
- 107
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Renal and Urology News
- Top 5M sites
- Earliest in this view
- Jul 6, 2026
Latest articles
Number of US Patents per Small-Molecule Drug Has Tripled Since 1990, Delaying Generics (opens the original)
Read excerpt
For small-molecule drugs, the number of US pharmaceutical patents per drug has more than tripled from 1990 to 2019, driven by increases in nonprimary patents, according to research reported in JAMA. Whereas primary patents address active ingredients, nonprimary patents cover other characteristics, such as formulations, delivery devices, or methods of use, study researchers explained, adding, “Large patent portfolios tend to delay competition because generic manufacturers generally must either ch
Pembrolizumab and Nivolumb Have Similar Outcomes in Advanced, Untreated Melanoma (opens the original)
Read excerpt
Initial treatment with either pembrolizumab or nivolumab leads to similar outcomes for patients with advanced, unresectable, or metastatic melanoma, according to research published in JAMA Network Open. Monoclonal antibodies targeting PD-1 are “mainstays” of cancer therapy, with pembrolizumab and nivolumab being used the most often, “but their comparative effectiveness and safety have not been established in a prospective randomized clinical trial,” study researchers explained. The researchers e
The 4Ms of Age-Friendly Care: What Matters, Medication, Mentation, and Mobility (opens the original)
Read excerpt
Ageism can be a common problem in the care of patients with cancer, potentially affecting multiple aspects of a patient’s care, but the 4M approach to nursing practice supports more age-friendly care. These approaches are discussed in a presentation at ONS Bridge 2026 by Sarah H. Kagan, PhD, RN, GCNS-BC, AOCN, FGSA, FAAN, gerontology clinical nurse specialist and Lucy Walker Honorary Term Professor of Gerontology Nursing at the Abramson Cancer Center at Pennsylvania Hospital and Division of Geri
Apixaban vs Warfarin Appears Less Risky for Advanced CKD With AFib (opens the original)
Read excerpt
Contemporary observational data suggest ischemic stroke risk is lower with anticoagulation vs nonuse, and specifically, apixaban vs warfarin in patients with atrial fibrillation (AFib) and stage 4-5 chronic kidney disease (CKD) who do not require dialysis. A retrospective cohort study incorporated a 3-group target trial emulation framework to evaluate the initiation of apixaban or warfarin versus no oral anticoagulant (OAC) therapy in stage 4-5 nondialysis CKD with AFib. Investigators culled dat
Help for Pain, Depression Has Not Increased in Chemo Recipients Despite Increased Screening - Oncology Nurse Advisor (opens the original)
Read excerpt
Although oncology practices report increased screening and management of pain and depression in patients receiving chemotherapy, the proportion of patients reporting that they received help for these conditions has not increased. These findings were published in JCO Oncology Practice. The Oncology Care Model (OCM), developed by the Centers for Medicare & Medicaid Services, was aimed at improving the screening and management of pain and depression in oncology. In this study, researchers studied p
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Renal and Urology News, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.